EP2599483A1 — 4-Phenylbutyric acid formulation
Assigned to Lunamed AG · Expires 2013-06-05 · 13y expired
What this patent protects
The present invention refers to a pharmaceutical composition for 4-phenylbutyric acid or its ions and a compound comprising a L-aspartate-D-alanine core structure. The pharmaceutical composition include organic salts of phenylbutyrate, polymorphs, hydrates or solvates thereof and…
USPTO Abstract
The present invention refers to a pharmaceutical composition for 4-phenylbutyric acid or its ions and a compound comprising a L-aspartate-D-alanine core structure. The pharmaceutical composition include organic salts of phenylbutyrate, polymorphs, hydrates or solvates thereof and co-crystals of phenylbutyric acid and at least one organic molecule, polymorphs, hydrates or solvates thereof, as well as their use in cancer therapy and other pharmaceutical applications.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.